|

Doravirine + tenofovir DF + lamivudine Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • Instituto Mexicano del Seguro Social1

Indications

  • Integrase Inhibitors, HIV; HIV PROTEASE INHIB1
  • HIV Associate Weight Loss1
  • Weight Change1
  • HIV-1-infection1
  • Weight Loss1

Other1 trial

Change in Body Weight and BMI in PWH with DOR/3TC/TDF Compared with INSTI
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.